The treatment of chronic myeloid leukemia uses matinib Tablets IP 400 mg because they attack cancer cells through their molecular pathways. The treatment stops leukemia cells from spreading because it blocks the proteins which control their growth and this effect results in continuous disease control. Patients who follow their prescribed treatment with Imatinib Tablets IP 400 mg exper... https://quickbloging.com/how-imatinib-tablets-ip-400-mg-help-manage-chronic-myeloid-leukemia/